CHARLES SCHWAB INVESTMENT MANAGEMENT INC - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 162 filers reported holding THERAPEUTICSMD INC in Q4 2020. The put-call ratio across all filers is 1.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q1 2022$327,000
-7.9%
858,241
-13.8%
0.00%
Q4 2021$355,000
-49.7%
996,132
+4.7%
0.00%
Q3 2021$706,000
-76.2%
951,038
-61.8%
0.00%
-100.0%
Q2 2021$2,962,000
-7.5%
2,488,953
+4.2%
0.00%0.0%
Q1 2021$3,202,000
+49.6%
2,389,510
+35.2%
0.00%0.0%
Q4 2020$2,140,000
-6.1%
1,767,917
+22.6%
0.00%0.0%
Q3 2020$2,278,000
+22.1%
1,441,485
-3.4%
0.00%0.0%
Q2 2020$1,866,000
+29.6%
1,492,687
+9.9%
0.00%0.0%
Q1 2020$1,440,000
-55.6%
1,358,236
+1.4%
0.00%
-50.0%
Q4 2019$3,243,000
-25.0%
1,340,041
+12.4%
0.00%
-33.3%
Q3 2019$4,326,000
+40.9%
1,191,712
+0.9%
0.00%
+50.0%
Q2 2019$3,070,000
-43.9%
1,180,641
+5.0%
0.00%
-50.0%
Q1 2019$5,477,000
+32.8%
1,124,517
+3.9%
0.00%
+33.3%
Q4 2018$4,123,000
-40.1%
1,081,895
+3.1%
0.00%
-40.0%
Q3 2018$6,882,000
+21.1%
1,049,059
+15.2%
0.01%
+25.0%
Q2 2018$5,682,000
+35.6%
910,429
+5.9%
0.00%
+33.3%
Q1 2018$4,189,000
-15.3%
859,997
+5.0%
0.00%
-25.0%
Q4 2017$4,948,000
+35.2%
819,043
+18.4%
0.00%
+33.3%
Q3 2017$3,659,0000.0%691,633
-0.4%
0.00%0.0%
Q2 2017$3,659,000
-18.9%
694,167
+10.8%
0.00%
-40.0%
Q1 2017$4,510,000
+38.0%
626,312
+10.6%
0.01%
+25.0%
Q4 2016$3,267,000
-10.6%
566,083
+5.5%
0.00%0.0%
Q3 2016$3,654,000
-16.0%
536,542
+4.9%
0.00%
-20.0%
Q2 2016$4,349,000
+35.2%
511,630
+1.8%
0.01%
+25.0%
Q1 2016$3,217,000
-29.9%
502,636
+13.6%
0.00%
-33.3%
Q4 2015$4,588,000
+71.1%
442,396
-3.3%
0.01%
+50.0%
Q3 2015$2,682,000
-21.0%
457,674
+6.0%
0.00%
-20.0%
Q2 2015$3,393,000
+33.7%
431,643
+2.9%
0.01%
+25.0%
Q1 2015$2,538,000
+113.8%
419,422
+57.3%
0.00%
+100.0%
Q4 2014$1,187,000
-16.5%
266,610
-12.9%
0.00%0.0%
Q3 2014$1,421,000
+33.6%
306,084
+27.2%
0.00%0.0%
Q2 2014$1,064,000
-22.7%
240,666
+10.3%
0.00%0.0%
Q1 2014$1,377,000
+50.2%
218,202
+24.1%
0.00%0.0%
Q4 2013$917,000
+123.1%
175,843
+31.4%
0.00%
+100.0%
Q3 2013$411,000
+20.2%
133,814
+2.5%
0.00%0.0%
Q2 2013$342,000130,5160.00%
Other shareholders
THERAPEUTICSMD INC shareholders Q4 2020
NameSharesValueWeighting ↓
Rubric Capital Management LP 5,344,302$2,031,0000.07%
Asset Management Group, Inc. 735,040$279,0000.06%
SANDERS MORRIS HARRIS LLC 512,633$194,0000.04%
State of Wyoming 165,187$63,0000.03%
C WorldWide Group Holding A/S 6,189,834$2,352,0000.03%
PURA VIDA INVESTMENTS, LLC 1,619,080$615,0000.02%
Traynor Capital Management, Inc. 367,991$139,0000.02%
EMFO, LLC 44,500$17,0000.02%
Platform Technology Partners 70,000$27,0000.01%
Kowal Investment Group, LLC 99,357$38,0000.01%
View complete list of THERAPEUTICSMD INC shareholders